NEUARTIGE GLUTAMINASEINHIBITOREN

European patent · EP3092236 · Deleted

Register entry

Publication number
EP3092236
Application number
EP15705845
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Jan 5, 2015
Published
Nov 16, 2016
Granted
Aug 26, 2020
Deleted
Aug 24, 2023
Reason
Annual fee unpaid
IPC classes
C07D 417/06 (2006.01)
C07D 417/08 (2006.01)
C07D 417/14 (2006.01)
C07D 285/135 (2006.01)
A61K 31/433 (2006.01)
A61P 35/00 (2006.01)
A61P 37/00 (2006.01)
Priority
IN 36CH2014 06.01.2014
IN 39CH2014 06.01.2014
IN 2639CH2014 29.05.2014
IN 2647CH2014 29.05.2014
IN 2783CH2014 06.06.2014
IN 3525CH2014 18.07.2014
IN 3612CH2014 24.07.2014
IN 3613CH2014 24.07.2014
IN 5438CH2014 31.10.2014
PCT application
PCT/IB2015/050075 05.01.2015
PCT publication
WO2015/101957 09.07.2015
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 24, 2023

    Deleted, fee unpaid

    Published in Swissreg on 24.08.2023

  2. Nov 21, 2020

    Agent entered

    Representative
    Novagraaf International SA, Chemin de l'Echo 3, 1213 Onex

    Published in Swissreg on 21.11.2020

  3. Aug 26, 2020

    Granted

    Published in Swissreg on 26.08.2020

Parties

Holder

Rhizen Pharmaceuticals S.A.

Fritz Courvoisier 40, 2300 La Chaux de Fonds

Agent

Novagraaf International SA

Chemin de l'Echo 3, 1213 Onex

Inventor

SWAROOP, Merikapudi Gayatri

Hyderabad 500078, IN

VAKKALANKA, Swaroop Kumar Venkata Satya

CH-2300 La Chaux de Fonds

VISWANADHA, Srikant

Hyderabad 500078, IN

BABU, Govindarajulu

Hyderabad 500078, IN

BHAVAR, Prashant Kashinath

Hyderabad 500078, IN

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.